EZH2 and breast carcinoma: Through epigenetic mechanism, EZH2 suppresses miR-381 expression in breast cancer to promote cisplatin resistance89 and suppresses recombinant F-Box protein 32 expression in gastric cancer, leading to 5-fluorouracil resistance.90